Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

IHeart Japan

Explore full profile

IHeart Japan: Expert remote cardiovascular second opinions and medical tourism services to Japan

Kyoto, JapanFounded 2013Biotech & Life Sciences
Valuation $10–25M Last recorded · 2021
Headcount <100 Current team size
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for IHeart Japan and the history behind them.

About IHeart Japan

iHeart Japan Co., Ltd., founded in 2015 by cardiovascular surgeon Dr. Kohtaro Ebisawa, is a medical service company based in Nagano, Japan. The company specializes in providing expert remote second opinions in cardiovascular medicine, leveraging a team of board-certified cardiologists to review medical records, analyze diagnostic tests, and offer personalized treatment recommendations to patients globally. Beyond second opinions, iHeart Japan is a prominent medical tourism provider, facilitating access to advanced medical care in Japan for international patients. This service encompasses medical consultations, treatment coordination, travel and accommodation arrangements, and translation/interpretation, supported by a network of over 100 medical institutions. The company has successfully assisted over 1,000 patients. In November 2021, iHeart Japan expanded its offerings with the "Doctor's Agent" business, a career support service for medical professionals, assisting with career transitions and placements. The company's diversified business model generates revenue through fees for second opinions, comprehensive medical tourism packages, and services for its Doctor's Agent program. iHeart Japan recently secured 100 million yen in a seed round to further expand its operations. Keywords: remote second opinion, cardiovascular medicine, medical tourism, Japan healthcare, Doctor's Agent, medical career support, Dr. Kohtaro Ebisawa, international patients, medical consultations, treatment coordination, medical interpretation, seed funding.

Source: Dealroom company data

At a glance

Founded
2013
Headquarters
Kyoto, Japan
Sector
Biotech & Life Sciences

Investors

9 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A4 investors entered at this stage

  • Miyako Capital
  • Mitsubishi UFJ Capital
  • UntroD Capital
  • SBI Investment

Series B and later5 investors entered at this stage

  • Future Venture Capital
  • The Miyazaki Bank
  • NCB Venture Capital
  • Resona Capital
  • Kyoto University Innovation Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇯🇵 Japan100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about IHeart Japan on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See IHeart Japan on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.